Octapharma Schweiz Octapharma AG
OVERVIEW
OCTAPHARMA.CH RANKINGS
Date Range
Date Range
Date Range
LINKS TO WEB SITE
Focused on improving patient care. Understanding the fragility and value of life. Developing future solutions for unmet patient needs. Octapharma Group publishes 2017 annual results reporting revenue of 1. 72 billion and operating income of 349 million.
Click here to access a map displaying the locations of Octapharma offices and plants, if you require information on Octapharma activities in a country not listed, please contact Octapharma Headquarters. Declaration of Support and Payments. Focused on improving patient care. Understanding the fragility and value of life.
Click here to access a map displaying the locations of Octapharma offices and plants, if you require information on Octapharma activities in a country not listed, please contact Octapharma Headquarters. You are now leaving the Octapharma website.
Click here to access a map displaying the locations of Octapharma offices and plants, if you require information on Octapharma activities in a country not listed, please contact Octapharma Headquarters.
Rapid Push ist eine neue Applikationsmethode, bei der subkutane Immunglobuline ohne Pumpe direkt aus. Weitere News finden Sie hier. Bitte haben Sie dafür Verständnis.
Click here to access a map displaying the locations of Octapharma offices and plants, if you require information on Octapharma activities in a country not listed, please contact Octapharma Headquarters.
Die Jahrestagung Swisstransfusion ist der jährliche Kongress für Entscheidungsträger und Anwender im Bereich der Transfusionsmedizin, Hämapherese, - und der Immunhämatologie. Medizinisches Fachpersonal, Mitarbeitende der Blutspendedienste und deren Partner treffen sich hier. Die Swisstransfusion 2015 fand vom 23. Das wissenschaftliche Programm der Tagung beinhaltete u.
WHAT DOES OCTAPHARMA.CH LOOK LIKE?
OCTAPHARMA.CH HOST
WEBSITE IMAGE
SERVER OS
I detected that this website is utilizing the Apache server.PAGE TITLE
Octapharma Schweiz Octapharma AGDESCRIPTION
Seit der Gründung 1983 hat sich Octapharma auf die Entwicklung und Herstellung von Präparaten aus menschlichem Plasma spezialisiert. Schwerpunkte sind hochreine, virusinaktivierte Arzneimittel zur Therapie von Erkrankungen in den Bereichen Hämathologie, Immunologie und Intensivmedizin.CONTENT
This site octapharma.ch states the following, "Focused on improving patient care." We noticed that the webpage also said " Understanding the fragility and value of life." It also stated " Developing future solutions for unmet patient needs. Octapharma Group publishes 2017 annual results reporting revenue of 1. 72 billion and operating income of 349 million. Lachen, Switzerland, March 1st, 2018 Over the last six years, the Octapharma Group has accomplished." The header had Octapharma as the highest ranking keyword. It was followed by Pharma and Albunorm which isn't as ranked as highly as Octapharma.VIEW MORE DOMAINS
Click here to access a map displaying the locations of Octapharma offices and plants, if you require information on Octapharma activities in a country not listed, please contact Octapharma Headquarters. Declaration of Support and Payments. Focused on improving patient care. Understanding the fragility and value of life.
Click here to access a map displaying the locations of Octapharma offices and plants, if you require information on Octapharma activities in a country not listed, please contact Octapharma Headquarters. You are now leaving the Octapharma website.
Click here to access a map displaying the locations of Octapharma offices and plants, if you require information on Octapharma activities in a country not listed, please contact Octapharma Headquarters.
Rapid Push ist eine neue Applikationsmethode, bei der subkutane Immunglobuline ohne Pumpe direkt aus. Weitere News finden Sie hier. Bitte haben Sie dafür Verständnis.